Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation

PaperCitations, authors & open-access status

Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 159 citations, 2018 year and closed oa status.

159
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Minhui Dai
Author
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Topic
Inflammasome and immune disorders
Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Topic
470M+ articles · free account